UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.86B |
| 2 |
Prologis
PLD
|
+$1.82B |
| 3 |
Welltower
WELL
|
+$1.61B |
| 4 |
Microsoft
MSFT
|
+$1.53B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Realty Trust
DLR
|
+$822M |
| 2 |
AutoZone
AZO
|
+$481M |
| 3 |
Extra Space Storage
EXR
|
+$300M |
| 4 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$284M |
| 5 |
Meta Platforms (Facebook)
META
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.15% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.43% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Rhinebeck Bancorp
RBKB
$201M
| $694 | ﹤0.01% |
45
+21
| +88% | +$295 |
2025 Q4
1 quarter
|
|
3702
Inogen
INGN
$164M
| $686 | ﹤0.01% |
+111
| New | +$685 |
2026 Q1
0 quarters
|
|
3703
Anavex Life Sciences
AVXL
$138M
| $682 | ﹤0.01% |
222
-161,902
| -100% | -$701K |
2025 Q1
4 quarters
|
|
3704
Candel Therapeutics
CADL
$761M
| $676 | ﹤0.01% |
+138
| New | +$751 |
2026 Q1
0 quarters
|
|
3705
Gray Television
GTN
$468M
| $673 | ﹤0.01% |
+155
| New | +$728 |
2026 Q1
0 quarters
|
|
3706
Health Catalyst
HCAT
$133M
| $664 | ﹤0.01% |
+523
| New | +$984 |
2026 Q1
0 quarters
|
|
3707
First Trust Dow Jones Select MicroCap Index Fund
FDM
$261M
| $657 | ﹤0.01% |
+8
| New | +$668 |
2026 Q1
0 quarters
|
|
3708
Vera Bradley
VRA
$147M
| $648 | ﹤0.01% |
+205
| New | +$584 |
2026 Q1
0 quarters
|
|
|
ITRG
3709
Integra Resources
ITRG
$534M
| $636 | ﹤0.01% |
+233
| New | +$862 |
2026 Q1
0 quarters
|
|
3710
Critical Metals Corp
CRML
$1.01B
| $635 | ﹤0.01% |
+80
| New | +$922 |
2026 Q1
0 quarters
|
|
3711
SP Funds S&P 500 Sharia ETF
SPUS
$3.35B
| $626 | ﹤0.01% |
+13
| New | +$658 |
2026 Q1
0 quarters
|
|
|
EU
3712
enCore Energy
EU
$188M
| $603 | ﹤0.01% |
+335
| New | +$856 |
2026 Q1
0 quarters
|
|
|
TBRG
3713
DELISTED
TruBridge
TBRG
| $600 | ﹤0.01% |
41
| – | – |
2025 Q4
1 quarter
|
|
3714
Fidelity Enhanced Large Cap Value ETF
FELV
$3.48B
| $593 | ﹤0.01% |
17
| – | – |
2025 Q4
1 quarter
|
|
3715
Black Diamond Therapeutics
BDTX
$105M
| $586 | ﹤0.01% |
+275
| New | +$654 |
2026 Q1
0 quarters
|
|
3716
Johnson Outdoors
JOUT
$448M
| $558 | ﹤0.01% |
+12
| New | +$559 |
2026 Q1
0 quarters
|
|
3717
Stem
STEM
$40M
| $548 | ﹤0.01% |
+62
| New | +$832 |
2026 Q1
0 quarters
|
|
3718
NACCO Industries
NC
$268M
| $520 | ﹤0.01% |
+10
| New | +$516 |
2026 Q1
0 quarters
|
|
3719
Anterix
ATEX
$1.66B
| $496 | ﹤0.01% |
13
| – | – |
2025 Q4
1 quarter
|
|
3720
iShares MSCI France ETF
EWQ
$332M
| $477 | ﹤0.01% |
+11
| New | +$498 |
2026 Q1
0 quarters
|
|
|
LINE
3721
Lineage Inc
LINE
$7.84B
| $459 | ﹤0.01% |
14
+11
| +367% | +$407 |
2024 Q3
6 quarters
|
|
3722
Cable One
CABO
$63.2M
| $456 | ﹤0.01% |
5
-12,179
| -100% | -$1.19M |
2015 Q3
42 quarters
|
|
|
OPRA
3723
Opera Ltd
OPRA
$1.56B
| $456 | ﹤0.01% |
32
| – | – |
2025 Q4
1 quarter
|
|
3724
Acme United Corp
ACU
$238M
| $449 | ﹤0.01% |
+10
| New | +$435 |
2026 Q1
0 quarters
|
|
|
SNBR
3725
DELISTED
Sleep Number
SNBR
| $443 | ﹤0.01% |
247
+164
| +198% | +$1.23K |
2025 Q4
1 quarter
|
|
Similar funds
UBS AM's Q1 2026 Portfolio in Review
As of Q1 2026, UBS AM held 3,871 positions worth $481B, up 1.7% from $473B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
UBS AM deployed $35.5B of net new capital in Q1 2026, opening 584 new positions and adding to 2,429 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Digital Realty Trust, an estimated $822M trimmed.
- UBS AM's largest Q1 2026 buy was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
- UBS AM added most to Broadcom in Q1 2026, an estimated $1.86B increase.
- UBS AM's biggest Q1 2026 reduction was Digital Realty Trust, cutting an estimated $822M.
- UBS AM fully exited CyberArk in Q1 2026, selling an estimated $139M.
- UBS AM's ten largest holdings make up 32% of its $481B portfolio in Q1 2026.
- UBS AM opened 584 new positions and closed 64 in Q1 2026.
- UBS AM's portfolio value rose 1.7% quarter-over-quarter to $481B.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.